Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IVBXF

Recent news which mentions IVBXF

Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
Tickers IVBXF SNY
Tags General News SNY
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Tickers ABBV AMRX BNTX BYSI
Tags GMTX VALN IVBXF
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags INCY NVS General
From Benzinga
FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting
Tickers IVBIY IVBXF LLY
Tags IVBIY IVBXF News
From Benzinga
FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab
Tickers IVBIY IVBXF LLY
Tags IVBIY IVBXF lung cancer
From Benzinga
Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate
Tickers IVBIY IVBXF
Tags IVBIY Market News Benzinga
From Benzinga
Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates
Tickers BOLT IVBIY IVBXF
Tags Market News Benzinga BOLT
From Benzinga
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Tickers IVBIY IVBXF LLY
Tags Biotech Health Care Market News
From Benzinga
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Tickers IVBIY IVBXF LLY
Tags Benzinga LLY Market News
From Benzinga
Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer
Tickers INCY IVBIY IVBXF
Tags Bile Duct Cancer Biotech Health Care
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.